Radiation Therapy

The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

A new study led by Ivan Martinez—associate professor in the WVU School of Medicine and Cancer Institute—found a link between a family of RNAs, the Y chromosome, and radiation sensitivity in male lung-cancer patients
News | Radiation Therapy | March 23, 2021
March 23, 2021 — The science behind the COVID-19 vaccine has the potential to do more than prevent cases of COVID-19...
Cancer tissue being bombarded by targeted alpha particles. The generator developed by Los Alamos National Laboratory holds uranium-230, which decays to thorium-226. Further decay produces short-lived daughter isotopes, emitting four more alpha particles resulting in a very high combined radiation dose to destroy cancer cells.

Cancer tissue being bombarded by targeted alpha particles. The generator developed by Los Alamos National Laboratory holds uranium-230, which decays to thorium-226. Further decay produces short-lived daughter isotopes, emitting four more alpha particles resulting in a very high combined radiation dose to destroy cancer cells.

News | Radiation Therapy | March 23, 2021
March 23, 2021 — Improved options for cancer treatment are on the way, thanks to a new system developed at Los Alamos...
Radiofrequency ablation for the palliative treatment of osseous metastases reduces pain and improves quality of life

Radiofrequency ablation for the palliative treatment of osseous metastases reduces pain and improves quality of life.

News | Interventional Radiology | March 19, 2021
March 19, 2021 — A minimally invasive treatment for patients whose cancer has spread to their bones provides quick and...
Boston Scientific's TheraSphere Y-90 Glass Microspheres enable selective internal radiation therapy (SIRT), or radioembolization, for hepatocellular carcinoma. This treats liver cancer with low toxicity using millions of microscopic glass beads containing radioactive yttrium (Y-90), delivered directly to liver tumors via catheter. The result in minimal radiation exposure to surrounding healthy tissue.

Boston Scientific's TheraSphere Y-90 Glass Microspheres enable selective internal radiation therapy (SIRT), or radioembolization, for hepatocellular carcinoma. This treats liver cancer with low toxicity using millions of microscopic glass beads containing radioactive yttrium (Y-90), delivered directly to liver tumors via catheter. The result in minimal radiation exposure to surrounding healthy tissue.

News | Radiation Therapy | March 18, 2021
March 18, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific's TheraSphere Y-90 Glass...
WVU Rockefeller Neuroscience Institute staff prepare a patient for a first-in-the-world clinical trial to investigate the use of focused ultrasound technology to treat opioid use disorder. (WVU Photo/Brian Persinger)

WVU Rockefeller Neuroscience Institute staff prepare a patient for a first-in-the-world clinical trial to investigate the use of focused ultrasound technology to treat opioid use disorder. (WVU Photo/Brian Persinger)

News | Focused Ultrasound Therapy | March 17, 2021
March 17, 2021 — On the heels of the country’s deadliest year for drug overdoses, the West Virginia University...
Stefan Vilsmeier Brainlab announced the acquisition of Mint Medical GmbH, a Heidelberg-based company that develops image reading and reporting software for clinical routine and research

Stefan Vilsmeier, President and CEO, Brainlab

News | Treatment Planning | March 10, 2021
March 10, 2021 — Brainlab announced the acquisition of Mint Medical GmbH, a Heidelberg-based company that develops...
Methodology for evaluation of tumor cell density (TCD) and allocation of radiotherapy response categories. (A) Virtual graticule of approximately 300 points applied to tumor area on a digital H&E section. (B) Demonstration of TCD point scoring. (C) Box and whisker plot to show the relationship between ΔTCD and American Joint Committee on Cancer (AJCC) Tumour Regression Grade System (TRG). (D, E) Allocation of three radiotherapy response groups according to change in TCD (ΔTCD) for short-course radiotherapy

Methodology for evaluation of tumor cell density (TCD) and allocation of radiotherapy response categories. (A) Virtual graticule of approximately 300 points applied to tumor area on a digital H&E section. (B) Demonstration of TCD point scoring. (C) Box and whisker plot to show the relationship between ΔTCD and American Joint Committee on Cancer (AJCC) Tumour Regression Grade System (TRG). (D, E) Allocation of three radiotherapy response groups according to change in TCD (ΔTCD) for short-course radiotherapy (SCRT) (D) and long-course chemoradiotherapy (LCRT) (E). The Kruskall-Wallis test was used for statistical comparisons. Image courtesy of BMJ

News | Radiation Oncology | March 09, 2021
March 9, 2021 — Cancers that are resistant to radiotherapy could be rendered susceptible through treatment with...
Axial fused PET/CT image shows intense uptake (arrowhead) in the deep pelvis corresponding to the left lobe of the prostate in a 62-year-old with a history of prostate cancer treated with radiation therapy.  The CT scan does not show the tumor. Image courtesy of the the Radiological Society of North America.

Axial fused PET/CT image shows intense uptake (arrowhead) in the deep pelvis corresponding to the left lobe of the prostate in a 62-year-old with a history of prostate cancer treated with radiation therapy. The CT scan does not show the tumor. Image courtesy of the the Radiological Society of North America.

Feature | Treatment Planning | March 05, 2021 | By Melinda Taschetta-Millane
The decision to offer radiation after prostatectomy for patients with recurrent prostate cancer is quite complex, and...
A new study by Rashi Mehta--a researcher with the WVU School of Medicine and Rockefeller Neuroscience Institute--finds that focused ultrasound may induce an immunological healing effect in the brains of Alzheimer's patients.

A new study by Rashi Mehta--a researcher with the WVU School of Medicine and Rockefeller Neuroscience Institute--finds that focused ultrasound may induce an immunological healing effect in the brains of Alzheimer's patients. Image courtesy of Caylie Silveria/West Virginia University

News | Focused Ultrasound Therapy | March 02, 2021
March 2, 2021 — West Virginia University scientists used magnetic resonance imaging (MRI) scans to show what happens...
“Distinction in Stereotactic Radiotherapy” offers comprehensive accreditation program for SRS/SBRT clinical practice and physics quality assurance

Image courtesy of Elekta

News | Stereotactic Body Radiation Therapy (SBRT) | February 26, 2021
February 26, 2021 — The Radiosurgery Society (RSS), a non-profit medical society dedicated to advancing the science and...
Radiology, radiation therapy, PACS, Enterprise image, X-ray, DR Systems, CT, MRI, contrast, ultrasound, VNA, product comparisons, comparison charts on ITN magazine.
Feature | February 17, 2021
Imaging Technology News (ITN) maintains more than 40 comparison charts of product specifications from various vendors,...
Insightec plans to expand in Latin America through a partnership with Strattner
News | Focused Ultrasound Therapy | February 16, 2021
February 16, 2021 — Insightec, a global healthcare company focused on creating the next generation of patient care,...
Immunotherapy-based precision medicine clinical trials being developed

Getty Images

News | Prostate Cancer | February 16, 2021
February 16, 2021 — Black men die more often of prostate cancer yet, paradoxically, have greater survival benefits from...
ZAP Surgical Systems, Inc. announced 18 new system orders in 2020 for its recently commercialized ZAP-X Gyroscopic Radiosurgery platform.
News | Stereotactic Body Radiation Therapy (SBRT) | February 12, 2021
February 12, 2021 — ZAP Surgical Systems, Inc. announced 18 new system orders in 2020 for its recently commercialized...

Images in 69-year-old man with biopsy-confirmed Gleason score 7 (3+4) prostate cancer. (a) Pretreatment axial T2-weighted fast spin-echo MRI scan (repetition time msec/echo time msec, 3820/97) shows tumor in midline anterior transition zone (arrow). (b) Intraoperative MRI scan shows contoured rectal wall (red line), prostate margin (blue outline), and region of interest (orange outline). Because the urethra was included in planned treatment volume, a suprapubic catheter was placed for continuous bladder drainage during treatment. (c) Intraoperative MRI scan shows focused ultrasound beam path (blue) overlaid on treatment plan. Rectangles illustrate each sonication spot. (d) Thermal map image obtained during treatment with heat deposition color coded in red overlaid on sonication spot. (e) Axial gadopentetate dimeglumine-enhanced MRI scan (230/2.97) obtained immediately after treatment shows devascularized ablated volume (arrows). (f) Corresponding T2-weighted fast spin-echo MRI scan (3820/97) at 5 months after ablation shows complete involution of transition zone. All seven cores from treatment area margins were negative for cancer at biopsy. Image courtesy of the Radiological Society of North America

News | Prostate Cancer | February 05, 2021
February 5, 2021 — A technique that delivers high-intensity focused ultrasound to targeted tissue under MRI guidance...
Real Time Imaging Technologies LLC iannounced that it has received U.S. Patent No. 10,898,070 IMAGING APPARATUS AND METHODS which covers the company’s methods for incorporating microlens into X-ray imaging detectors that enables significantly lower radiation dose without compromising image resolution.

Getty Images

News | Radiation Dose Management | February 05, 2021
February 5, 2021 — Real Time Imaging Technologies LLC has received U.S. Patent No. 10,898,070 IMAGING APPARATUS AND...
 GenesisCare — one of the leading oncology providers in the United States, Australia, Spain, and the United Kingdom — announced the addition of a game-changing adaptive therapy, the Ethos.
News | Radiation Therapy | February 04, 2021
February 4, 2021 —  GenesisCare — one of the leading oncology providers in the United States, Australia, Spain, and the...
Ludwig Chicago Co-director Ralph Weichselbaum and Kaiting Yang, a postdoctoral researcher in Weichselbaum's lab.

Ludwig Chicago Co-director Ralph Weichselbaum and Kaiting Yang, a postdoctoral researcher in Weichselbaum's lab. Image courtesy of Ludwig Cancer Research

News | Radiation Therapy | January 28, 2021
January 28, 2021 — A study led by Ludwig Chicago Co-director Ralph Weichselbaum, M.D., and Yang-Xin Fu, M.D., Ph.D., of...
Aquilion Exceed LB CT System offers industry’s largest bore and widest field-of-view
News | Computed Tomography (CT) | January 25, 2021
Janaury 25, 2021 —Canon Medical Systems USA, Inc. has received FDA clearance for the Aquilion Exceed LB CT system,...
An additional external-beam radiation dose delivered directly to the tumor can benefit the prospects of men with non-metastatic prostate cancer, without causing additional side effects. The risk of relapse within five years for these men is smaller than for men who did not receive this boost, as shown by a large-scale study initiated by UMC Utrecht in collaboration with the Netherlands Cancer Institute, UZ Leuven and Radboudumc.
News | Prostate Cancer | January 25, 2021
January 25, 2021 — An additional external-beam radiation dose delivered directly to the tumor can benefit the prospects...